2-Oxo-2-(4-(trifluoromethyl)phenyl)acetaldehyde

Collect

BASIC PARAMETERS Find an error

CAS: 1736-56-7
MF: C9H5O2F3
MW: 202.13
Synonyms: 2-Oxo-2-(4-(trifluoromethyl)phenyl)acetaldehyde

REPORT BY

Yongfang Li

Institute of Chemistry, Chinese Academy of Sciences
follow

Qing-Hua Fan

Institute of Chemistry, Chinese Academy of Sciences
follow

Zhiyong Wang

University of Science and Technology of China
follow

Xiaoming Feng

Sichuan University
follow

Lili Lin

Sichuan University
follow

Jian Zhou

East China Normal University
follow

Christopher Hulme

The University of Arizona
follow
Co-reporter: Steven Gunawan, Gary S. Nichol, Shashi Chappeta, Justin Dietrich, Christopher Hulme
pp: 4689-4692
Publication Date(Web):8 September 2010
DOI: 10.1016/j.tetlet.2010.06.131
The following article describes a concise synthesis of a collection of 4,5-dihydro-1H-benzo[e][1,4]diazepines fused to a hydantoin ring. Molecular complexity and biological relevance are high and structures are generated in a mere three steps, employing the Ugi reaction to assemble diversity reagents. The protocol represents a novel UDC (Ugi-deprotect-cyclize) strategy employed in the Ugi-5-component CO2-mediated condensation, followed by further cyclization under basic conditions, to afford the fused hydantoin. Mechanistic caveats, dependent on the aldehydes of choice will be revealed and a facile oxidation of the final products to imidazolidenetriones is briefly discussed.The article describes a concise synthesis of a collection of 4,5-dihydro-1H-benzo[e][1,4]diazepines fused to a hydantoin ring, generated in a mere three steps. The protocol employs the Ugi-5-component CO2-mediated condensation, benzodiazepine formation promoted by acidic conditions and basic treatment to afford the fused hydantoin. Mechanistic caveats, dependent on the aldehydes of choice will be revealed and a facile oxidation of the final products to imidazolidenetriones is briefly discussed.Image for unlabelled figure

Andrew Sutherland

University of Glasgow
follow

Zhanzhu Liu

Institute of Materia Medica
follow